IP Verse

Combinatorial Dna Screening

Patent No. EP4071250 (titled "Combinatorial Dna Screening") was filed by Myriad Womens Health on Mar 21, 2017. The application was issued on Mar 5, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEDec 4, 2025CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4071250

MYRIAD WOMENS HEALTH
Application Number
EP21214103A
Filing Date
Mar 21, 2017
Status
Granted And Under Opposition
Jan 31, 2025
Publication Date
Mar 5, 2025
External Links
Slate, Register , Google Patents